{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T07:07:12Z","timestamp":1765004832122},"reference-count":4,"publisher":"Elsevier BV","issue":"9120","license":[{"start":{"date-parts":[[1998,6,1]],"date-time":"1998-06-01T00:00:00Z","timestamp":896659200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet"],"published-print":{"date-parts":[[1998,6]]},"DOI":"10.1016\/s0140-6736(05)78614-1","type":"journal-article","created":{"date-parts":[[2005,4,9]],"date-time":"2005-04-09T07:46:19Z","timestamp":1113032779000},"page":"1930-1931","source":"Crossref","is-referenced-by-count":60,"title":["Raised plasma soluble Fas and Fas-ligand in alcoholic liver disease"],"prefix":"10.1016","volume":"351","author":[{"given":"Julien","family":"Ta\u00efeb","sequence":"first","affiliation":[]},{"given":"Philippe","family":"Mathurin","sequence":"additional","affiliation":[]},{"given":"Thierry","family":"Poynard","sequence":"additional","affiliation":[]},{"given":"Marie Anne","family":"Gougerot-Pocidalo","sequence":"additional","affiliation":[]},{"given":"Sylvie","family":"Chollet-Martin","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/S0140-6736(05)78614-1_bib1","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1084\/jem.182.5.1223","article-title":"Involvement of the CD95 (APO61\/fas) receptor and ligand in liver damage","volume":"182","author":"Galle","year":"1995","journal-title":"J Exp Med"},{"key":"10.1016\/S0140-6736(05)78614-1_bib2","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1002\/hep.1840190606","article-title":"Immunohistochemical detection of Fas antigen in liver tissue of patients with chronic hepatitis C","volume":"19","author":"Hiramatsu","year":"1994","journal-title":"Hepatology"},{"key":"10.1016\/S0140-6736(05)78614-1_bib3","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nm0396-317","article-title":"Fas ligand in human serum","volume":"2","author":"Tanaka","year":"1996","journal-title":"Nat Med"},{"key":"10.1016\/S0140-6736(05)78614-1_bib4","first-page":"3870","article-title":"Elevated soluble Fas (sFas) levels in nonhematopoietic human malignancy","volume":"56","author":"Midis","year":"1996","journal-title":"Cancer Res"}],"container-title":["The Lancet"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0140673605786141?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0140673605786141?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,27]],"date-time":"2019-01-27T08:59:32Z","timestamp":1548579572000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0140673605786141"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,6]]},"references-count":4,"journal-issue":{"issue":"9120","published-print":{"date-parts":[[1998,6]]}},"alternative-id":["S0140673605786141"],"URL":"https:\/\/doi.org\/10.1016\/s0140-6736(05)78614-1","relation":{},"ISSN":["0140-6736"],"issn-type":[{"value":"0140-6736","type":"print"}],"subject":[],"published":{"date-parts":[[1998,6]]}}}